Benralizumab 30 MG/ML [Fasenra]
Sponsors
Singapore General Hospital, University Hospital, Lille
Conditions
AsthmaAsthma AttackDRESS Syndrome
Phase 2
Benralizumab Initiated During Severe Asthma Attack
NCT04617171
Start: 2021-06-02End: 2023-08-31Target: 128Updated: 2021-07-23
Interest of a Targeted Therapy for the Treatment of a Severe Form of Hypersensitivity to Drug (DRESS Syndrome)
Not yet recruitingNCT06734884
Start: 2025-01-06End: 2029-09-01Target: 96Updated: 2025-01-17